BioSight
Companies
Pacira BioSciences, Inc. logo

PCRX

NASDAQBRISBANE, CA
Pacira BioSciences, Inc.

Pacira BioSciences develops and commercializes specialty pharmaceuticals and medical devices focused on pain management, including the injectable anesthetic EXPAREL, the intra-articular steroid ZILRETTA, and the cryotherapy device iovera. Pacira operates primarily in the commercialization stage, marketing these three products across surgical and chronic pain indications while pursuing expansion into additional therapeutic uses. The company is pursuing growth through product line extensions, market expansion, and strategic acquisitions.

Price history not yet available for PCRX.

Pipeline

No pipeline data on record yet.

Catalyst Calendar

No catalyst events on record for yet. Check back after the next daily ingest.

Disclaimer·BioSight aggregates publicly available data (SEC EDGAR, ClinicalTrials.gov, FDA, company press releases) and is provided as is for informational purposes only. Nothing here is investment, financial, legal, tax, or medical advice, or an offer to buy or sell any security. We make no warranty as to accuracy, completeness, or timeliness; dates and filings may contain errors or be superseded without notice; past events do not predict future outcomes. To the maximum extent permitted by law, BioSight, its operators, contributors, and affiliates disclaim all liability for any loss or damage arising from use of or reliance on this site. You are solely responsible for your own investment decisions — consult a licensed professional before acting on any information.

Unlock 12-month calendar